01
Clean
Debride the wound and remove dead tissue to expose a healthy bed for the membrane.
Epiprotect.
The highway to healing.
A biosynthetic membrane that mimics human skin. Epiprotect forms a cell-free temporary epithelium that delivers instant pain relief, an impermeable bacterial barrier, and a single-application path to natural healing.
- 15days Mean healing time
- VSS4 Best scar outcome
- 73m²/g Fiber surface area
- 1× Single application
Instant pain relief
Impermeable bacterial barrier
Applied only once
In Action
Watch Epiprotect in clinical use.
A short demonstration of how Epiprotect adheres to the wound and forms a temporary biosynthetic epithelium.
Demo Reel Watch Demo
What is Epiprotect
A skin-mimicking biosynthetic membrane.
Epiprotect is a cell-free, biosynthetic membrane built on S2Medical's patented eiratex® fiber technology. Its nanostructure mirrors human collagen, giving it extremely high biocompatibility and full functionality as a temporary epithelium.
AHI manufactures two variants of the platform: EPIPROTECT® 2117 (21 × 17 cm dressing for partial-thickness burns and acute wounds) and EPIPROTECT® Ulcer (vial-packaged dressing for diabetic, venous, pressure, and other chronic ulcers). Both stay attached until the wound is re-epithelialized and then naturally release.
- Moisture-regulating and semi-permeable
- Impermeable barrier to microbes and allergens
- Retains proteins and growth factors in the wound environment
- Sterile, preservative-free and with exceptionally low endotoxin levels
- No reported allergic reactions
Mechanism of Action
From application to natural release.
Six stages, from cleaned wound to flake-off, driven by eiratex®'s collagen-like nanostructure and 73 m²/g of active fiber surface area.
02
Apply
Place Epiprotect over the wound and press out air bubbles. Overlap 2–3 cm if using multiple dressings.
03
Adhere
The membrane attaches intimately to the wound, forming a cell-free temporary epithelium. No staples, glue, or suture required.
04
Protect
A bacterial barrier seals the wound while remaining gas permeable, allowing oxygen and water vapor to pass through.
05
Heal
Growth factors and proteins are retained in the environment; inflammatory factors and endotoxins are actively absorbed.
06
Release
Once re-epithelialization is complete, the dressing dries out at the margin and naturally lifts off the healed skin.
Indications
The new standard of care at burn centers.
Adopted across burn centers worldwide, from Sweden and the UK to the UAE, KSA, and Nigeria. Epiprotect covers the full spectrum of burn and graft care.
Burns
Partial-thickness & second-degree
- Scald burns (superficial to mid-dermal)
- Flame burns, including facial burns
- Infected burns with anti-microbial protocol
- Replaces xenografts and allografts
Surgical
Graft & donor site management
- Skin graft donor sites
- Temporary cover for excised wounds pre-transplant
- Post-operative protective barrier
- Non-adherent to deep dermal areas
Chronic
Ulcers & exuding wounds
- Chronic leg & pressure ulcers
- Diabetic foot ulcers
- Complicated exuding wounds
- Prevents exudate formation
Fully compatible with antibiotics. Topical water-soluble anti-microbials can be applied through the dressing when infection risk is present, without compromising adhesion.
The Epiprotect Advantage
Outperforms across every clinical metric.
Head-to-head published comparison of Epiprotect against leading burn-care modalities.
| Property | Epiprotect | Biobrane | Suprathel | Xenograft | SSD (Flamazine) | Silver Foams |
|---|---|---|---|---|---|---|
| Mean healing time | 15 days | 32 days | 38 days | Longer | 22+ days | ~22 days |
| Infection rate | 7.7% | 22% | 14.3% | – | Higher | Higher |
| Pain score (1–10) | 1 | 2 | 1.5 | – | Higher | – |
| Scar quality (VSS) | 4Majid et al. | – | – | Inferior | – | – |
| Single application | ✓ | ✓ | ✓ | × | × | × |
| Near-total transparency | ✓ | Partial | × | × | × | × |
| Impermeable to bacteria | ✓ | Mixed | Mixed | × | × | Mixed |
| 100% animal/human-free | ✓ | × | ✓ | × | ✓ | ✓ |
Now our children play and laugh instead of scream and cry.
"We can release our patients earlier by using Epiprotect."
European burn center
"Follow-ups hardly take any time at all with Epiprotect."
Adopted across 10+ hospitals worldwide
Clinical Advantages
A single dressing. A whole new standard.
Outstanding pain reduction
Tight wound adherence covers exposed nerve endings, so patients rarely require analgesics.
Lower infection rates
Impermeable microbial barrier reported infection at 7.7%, well below Biobrane (22%) and Suprathel (14.3%).
Superior scar quality
Prevents premature wound contraction and myofibroblast activation, improving long-term cosmetic outcomes.
Near-total transparency
Monitor wound progress without removing the dressing, reducing follow-up time and disturbance.
Conforms to any surface
Superior conformability. Even facial burns can be dressed efficiently without compromise.
Apply once, done
Stays attached until re-epithelialization, then naturally releases. No painful changes, no trauma.
Proven Outcomes
Published evidence. Real patients.
A selection of peer-reviewed studies and case reports documenting Epiprotect's performance in partial-thickness burns, donor sites, and chronic wounds.
15days
Fastest healing time in class
Mean healing of 15 days, less than half the time of Biobrane (32 days) or Suprathel (38 days) across a head-to-head study of partial-thickness burns.
Gallagher et al. · Multi-modalityp=0.035
Significantly faster than standard of care
Epiprotect-treated partial-thickness burns healed in a mean of 11 days vs ~23 days on SSD (Flamazine), with significantly less pain throughout treatment.
Aboelnaga et al. · Burns 2018VSS 4
Best-documented scar outcome
Epiprotect achieved a Vancouver Scar Scale score of 4, outperforming non-adherent gauze (VSS 6), with scar quality superior to xenograft in randomized trial.
Majid et al. · Karlsson et al.Day 14
Facial & pediatric burns fully resolved
Case reports across Sweden, UAE, and Nigeria show full re-epithelialization of infected partial-thickness facial and pediatric burns by day 14–21, with minimal pain during treatment.
Case series · Multi-center Why it performs
- Eiratex® nanostructure mimics human collagen for full biocompatibility
- 73 m²/g of active surface area absorbs inflammatory factors & endotoxins
- Intimate adherence covers nerve endings for instant pain relief
- Retains growth factors and proteins in the healing environment
- Prevents myofibroblast contraction, improving final scar quality
Made in Saudi Arabia 
Officially Certified Saudi Made Program
Locally manufactured by AHI.
Through a strategic partnership with S2Medical (Sweden), AHI manufactures both EPIPROTECT® 2117 (burn & acute wound dressing) and EPIPROTECT® Ulcer (chronic ulcer dressing) at our Riyadh cleanroom facility — Saudi-made advanced wound care delivered to hospitals across the Kingdom and the wider GCC.
Officially Certified Saudi Made Program Specifications
Product & regulatory details.
- Product
- Epiprotect® 2117 Biosynthetic Wound Dressing
- Composition
- Biosynthetic eiratex® membrane (sugar-polymer fibers)
- Origin
- 100% free from animal or human tissue
- Indication
- Partial-thickness burns, donor sites, chronic ulcers & exuding wounds
- Fiber Surface Area
- ~73 m² per gram
- Wear Time
- Single application, remains until re-epithelialization
- Permeability
- Gas-permeable · Moisture-regulating · Bacteria-impermeable
- Medical Device Class
- Class IIb
- Regulatory Status
- Local market registration in progress
- Quality Standards
- ISO 13485 · ISO 14971 · ISO 10993
- Sterilization
- Single-use sterile · Preservative-free
- Packaging
- Sealed sterile vial · Multiple size formats
- Manufacturer
- Arabian House Industries · Riyadh, KSA
- Technology Partner
- S2Medical AB, Sweden
Events & Engagements
Epiprotect in the field.
In-service training, conferences, and clinical engagements where AHI introduced Epiprotect to burn and wound care teams across the Kingdom and the region.
2026
1 Engagement
2026 1 photo In-Service Training
In-Service Training · 2026
Continued in-service training at hospital sites, walking through Epiprotect application across burn and wound care indications.
2025
2 Engagements
2025 1 photo Conference
Second Wound Care International Conference · 2025
AHI presented Epiprotect at the second international wound care conference, contributing to the regional dialogue on advanced wound healing.
2025 1 photo In-Service Training
In-Service Training · 2025
An in-service training session conducted by AHI to share Epiprotect application techniques and best practices with clinical teams.
2024
1 Engagement
2024 1 photo Conference
International Conference for the Diabetic Foot · 2024
Epiprotect featured at the international diabetic foot conference, alongside clinicians focused on complex foot wound management.
2023
1 Engagement
2023 1 photo Riyadh · Conference
International Diabetic Foot Conference, Riyadh · 2023
AHI showcased Epiprotect at the international diabetic foot conference in Riyadh, engaging with regional specialists on burn and wound care.
Bring Epiprotect to your facility.
Talk to AHI about availability, clinical training, and distribution of Epiprotect across the Kingdom and the wider GCC.